3 results match your criteria aes vaes

  • Page 1 of 1

The natural history of vascular and other complications in patients treated with nilotinib for chronic myeloid leukemia.

Blood Adv 2019 04;3(7):1084-1091

Department of Clinical Haematology, Austin Hospital, Melbourne, Australia.

Although second-generation tyrosine kinase inhibitors (TKIs) show superiority in achieving deep molecular responses in chronic myeloid leukemia in chronic phase (CML-CP) compared with imatinib, the differing adverse effect (AE) profiles need consideration when deciding the best drug for individual patients. Long-term data from randomized trials of nilotinib demonstrate an increased risk of vascular AEs (VAEs) compared with other TKIs, although the natural history of these events in response to dose modifications or cessation has not been fully characterized. We retrospectively reviewed the incidence of nilotinib-associated AEs in 220 patients with CML-CP at 17 Australian institutions. Read More

View Article and Full-Text PDF

Ontology-Based Vaccine Adverse Event Representation and Analysis.

Adv Exp Med Biol 2017 ;1028:89-103

University of Michigan Medical School, 1301 Medical School Research Building III, 1150 W, Medical Center Dr, Ann Arbor, MI, 48109, USA.

Vaccine is the one of the greatest inventions of modern medicine that has contributed most to the relief of human misery and the exciting increase in life expectancy. In 1796, an English country physician, Edward Jenner, discovered that inoculating mankind with cowpox can protect them from smallpox (Riedel S, Edward Jenner and the history of smallpox and vaccination. Proceedings (Baylor University. Read More

View Article and Full-Text PDF

Ontology-based combinatorial comparative analysis of adverse events associated with killed and live influenza vaccines.

PLoS One 2012 28;7(11):e49941. Epub 2012 Nov 28.

National Center for Integrative Biomedical Informatics, University of Michigan, Ann Arbor, MI, USA.

Vaccine adverse events (VAEs) are adverse bodily changes occurring after vaccination. Understanding the adverse event (AE) profiles is a crucial step to identify serious AEs. Two different types of seasonal influenza vaccines have been used on the market: trivalent (killed) inactivated influenza vaccine (TIV) and trivalent live attenuated influenza vaccine (LAIV). Read More

View Article and Full-Text PDF
  • Page 1 of 1